SamanTree Medical has secured $14 million in Series B financing to advance its innovative Histolog® Scanner technology and expand into the U.S. market.

Information on the Target

SamanTree Medical is a premier medical technology company focused on transforming surgical outcomes through innovative imaging solutions. The company's flagship product, the Histolog® Scanner, utilizes cutting-edge ultra-fast confocal microscopy to facilitate real-time high-resolution imaging of fresh tissue surfaces during surgical procedures. This groundbreaking technology aims to enable surgeons and pathologists to perform intra-operative assessments with unprecedented speed and accuracy compared to traditional methods.

Recently, SamanTree Medical completed a successful Series B financing round, securing $14 million to further enhance the development and commercialization of its flagship Histolog Scanner. The funding will also support the company's expansion strategies across Europe and the United States, with plans to enrich their digital offerings and clinical capabilities.

Industry Overview in the Target’s Specific Country

Switzerland and Belgium are notable hubs for medical technology and innovation, hosting a thriving environment conducive for startups and established firms alike. The healthcare technology sector in Switzerland